Nearly 2,000 companies on the New Third Board have submitted their semi-annual reports. These innovative companies made a net profit of over 100 million yuan in the first half of the year.
2024-08-27
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
Beijing News Shell Finance (Reporter Huang Xinyu) Entering the last week of August, the first half "report card" of companies listed on the New Third Board began to enter the final stage.
The official website of the National Equities Exchange and Quotations (i.e., the operating entity of the New Third Board) shows that as of August 25, the number of companies listed on the New Third Board totaled 6,102, of which 2,169 were in the Innovation Layer and 3,933 were in the Basic Layer. Also as of August 25, Wind showed that 908 companies in the current Innovation Layer had released their 2024 semi-annual reports, of which 761 had positive net profits attributable to parent company shareholders (i.e., "net profits attributable to parent companies"), with a profitability of approximately 83.81%; and from the perspective of the Basic Layer, 2,033 companies have released their first-half results, of which 1,038 had positive net profits attributable to parent companies.
Specifically, among the 761 companies listed on the Innovation Layer of the New Third Board with positive net profits attributable to their parent companies, 34 companies achieved net profits attributable to their parent companies of more than 50 million yuan in the first half of 2024; and those with net profits exceeding 100 million yuan occupied five seats in the top ten.
The five companies are Huaqiang Fangte (834793.NQ) with 352 million yuan, Fengyuan Tire (872663.NQ) with 117 million yuan, Xiansheng Xiangrui (873821.NQ) with 116 million yuan, Tiangong Co., Ltd. (834549.NQ) with 104 million yuan and Jinxun Co., Ltd. (870844.NQ) with 113 million yuan.
Source: Wind
It is worth noting that unlike the other four companies that were listed on the New Third Board before the Beijing Stock Exchange announced its establishment in 2021, Xiansheng Xiangrui from Beijing is a new company listed on the New Third Board in 2022.
The semi-annual report shows that Innovent Biologics is a biopharmaceutical company that produces tuberculin purified protein derivatives (TB-PPD) and BCG purified protein derivatives (BCG-PPD), focusing on anti-infection, infectious diseases and vaccines. Innovent Biologics is also a specialized and innovative "little giant" enterprise in Beijing, which was successfully listed on the New Third Board two years after its establishment.
Also as of August 25, among the top ten companies in terms of net profit attributable to shareholders of the Innovation Tier, there are Zhonghuanjie (874175.NQ) and Olais (874275.NQ), which are also companies listed on the New Third Board in recent years.
An investment banker told the reporter that special attention needs to be paid to companies that have been listed on the New Third Board or entered the Innovation Board in recent years, especially those that achieved annual net profit attributable to parent companies of more than 50 million yuan.
Judging from the year-on-year growth rate of net profit attributable to the parent company, which can partially reflect the growth situation, as of August 25, 152 of the 176 innovative layer companies with positive profits doubled their profits year-on-year, accounting for about 86.36%. Among them, the top ten innovative layer companies have achieved a year-on-year growth rate of net profit attributable to the parent company of more than 800% in the first half of this year.
Source: Wind
From the perspective of R&D, among the 908 innovation-tier enterprises that have completed the disclosure of semi-annual reports as of August 25, there are 10 enterprises whose R&D expenses account for more than 45% of their operating income. Among them, Hehua Ruibo (873940.NQ) from Beijing had R&D expenses accounting for 11,792.06% of its operating income in the first half of this year.
Source: Wind
According to the official website, Hehua Ruibo is a Beijing-based specialized and innovative small and medium-sized enterprise that focuses on the research and development, manufacturing of surgical robots and the construction of intelligent surgical management platforms. On January 6, 2020, Peking Union Medical College Hospital used the HURWA® Hehua™ robot to complete the first domestically produced robotic total knee replacement surgery, breaking the long-term monopoly of imported products in this field.
But it is also worth noting that Wind shows that Hehua Ruibo’s net loss in the first half of this year was approximately 41.8578 million yuan.
According to the reporter's statistics, it is expected that by the end of August, more than 4,000 NEEQ companies will have handed in their "report cards" for the first half of the year. By then, the development of more than 6,000 NEEQ companies in the first half of the year will be fully displayed.
Edited by Chen Li, Proofread by Liu Baoqing
